Your browser doesn't support javascript.
loading
Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study.
Lesueur, Paul; Damaj, Gandhi; Hoang-Xuan, Khê; Roland, Virginie; Schmitt, Anna; Chinot, Olivier; Fabbro, Michel; Agapé, Philippe; Moluçon-Chabrot, Cécile; Chebrek, Safia; Alentorn, Agusti; Feuvret, Loic; Delgadillo, Daniel; Stefan, Dinu; Choquet, Sylvain; Nichelli, Lucia; Mokhtari, Karima; Mathon, Bertrand; Dureau, Sylvain; Soussain, Carole; Houillier, Caroline.
Afiliación
  • Lesueur P; Department of Radiation Oncology, Centre François Baclesse, Caen, France.
  • Damaj G; Department of Radiation Oncology Centre Guillaume le Conquérant, Le Havre, France.
  • Hoang-Xuan K; Normandie Université, Université de Caen Normandie (UNICAEN), Commission de l'Énergie Atomique (CEA), Centre National de la Recherche Scientifique (CNRS), Imagerie et Stratégies Thérapeutiques pour les Cancers et Tissus Cérébraux (ISTCT)/CERVOxy group, GIP Cyceron, Caen, France.
  • Roland V; Hematology Institute, University Hospital, Normandie Université, Centre Hospitalier Universitaire (CHU), Cote de Nacre, Caen, France.
  • Schmitt A; Department of Neuro-oncology, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Institut Hospitalier Universitaire (IHU), Institut du Cerveau et de la Moelle (ICM), Groupe Hospitalier Pitié Salpetrière, Paris, France.
  • Chinot O; Department, of Hematology, Hopital Saint Jean, Perpignan, France.
  • Fabbro M; Department of Hematology, Institut Bergonié, Bordeaux, France.
  • Agapé P; Department of Neuro-oncology, Hopital de la Timone, Marseille, France.
  • Moluçon-Chabrot C; Department of Medical Oncology, Institut de Cancérologie de Montpellier, Montpellier, France.
  • Chebrek S; Department of Hematology, Institut de Cancérologie de l'Ouest, Nantes, France.
  • Alentorn A; Department of Hematology, CHU Estaing, Clermont Ferrand, France.
  • Feuvret L; Department of Hematology, Hopital d'Avignon, Avignon, France.
  • Delgadillo D; Department of Neuro-oncology, Assistance Publique-Hôpitaux de Paris (APHP), Sorbonne Université, Institut Hospitalier Universitaire (IHU), Institut du Cerveau et de la Moelle (ICM), Groupe Hospitalier Pitié Salpetrière, Paris, France.
  • Stefan D; Department of Radiation Oncology, APHP, Pitié Salpetrière, Paris, France.
  • Choquet S; Department of Psychiatry, APHP, Pitié Salpetrière, Paris, France.
  • Nichelli L; Department of Radiation Oncology, Centre François Baclesse, Caen, France.
  • Mokhtari K; Cinical Hematology Unit, Groupe Hospitalier Pitié-Salpêtrière, APHP-Sorbonne, Paris, France.
  • Mathon B; Department of Neuroradiology.
  • Dureau S; Department of Neuropathology, and.
  • Soussain C; Department of Neurosurgery, APHP, Pitié Salpetrière, Paris, France.
  • Houillier C; Department of Statistics, and.
Blood Adv ; 6(16): 4807-4815, 2022 08 23.
Article en En | MEDLINE | ID: mdl-35772168

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias del Sistema Nervioso Central / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Neoplasias del Sistema Nervioso Central / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans / Middle aged Idioma: En Revista: Blood Adv Año: 2022 Tipo del documento: Article País de afiliación: Francia